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I.   Executive Summary and Overall Evaluation 
 
The 2015 Exploration Medical Capability (ExMC) Standing Review Panel (from here on 
referred to as the SRP) met for a site visit in Houston, TX on December 10 - 11, 2015.  The SRP 
reviewed the updated research plan for the Risk of Adverse Health Outcomes and Decrements in 
Performance due to Inflight Medical Conditions (ExMC Risk). 
 
In general, the SRP is pleased with the progress of the research plan and the logical, 
chronological, and manageable way the Gaps are addressed.  The ExMC Research Plan 
presented to the SRP in December 2015 fulfilled this Element’s responsibility to provide three 
types of deliverables: 1) knowledge about medical issues of concern for exploration missions; 2) 
medical informatics tools; and 3) medical technologies.  This ExMC Research Plan appears to be 
more tightly coupled to engineering systems development than any plan this SRP has previously 
evaluated and that is a very positive feature.  Formally dividing ExMC’s work into operations 
research, information resources, and technology development allows for closer interactions 
between clinicians and engineers in designing future medical and flight systems. 
 
The ExMC Element has identified two paradigms for space exploration: 1) the low Earth orbit 
(LEO) paradigm and 2) the outside of LEO paradigm.  The current plan is premised on the 
exploration paradigm, in which the crew most likely would have limited access to regular 
resupply and evacuation.  Thus, the current plan appropriately accounts for the need for 
autonomy in delivering event-driven care in deep space where communication with Earth will be 
delayed or absent.  Given that other organizations are currently focusing on the LEO paradigm, 
the SRP agrees with the research plan’s emphasis on risks beyond LEO. 
 
The updated ExMC Research Plan has consolidated 24 open Gaps in medical risk (out of 33 
previously identified Gaps, 24 are currently open and nine are now closed) into 13 new Gaps.  
Among the revised set of 13 Gaps in medical risk, seven are existing Gaps and six are new Gaps.  
This new classification of Gaps makes the current plan more logical and easier to understand.  
Each of the 13 new Gaps of medical risk can now be thought of as falling into one of three 
categories: 1) operational Gaps (Med-01 – Med-06; 2) information resource Gaps (Med-07 – 
Med-10); and 3) technology Gaps (Med-11 – Med-13).  These three Gap categories focus, 
respectively, on policies, software, and hardware. 
 
The ExMC Element research responsibilities now include the previous ExMC Risks and three 
additional Risks.  These include: 1) The Risk of Bone Fractures Due to Spaceflight-Induced 
Changes in Bone; 2) The Risk of Renal Stone Formation; and 3) The Risk of Ineffective or Toxic 
Medications Due to Long Term Storage.  The SRP agrees that the new Risks are relevant to the 
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Finally, incorporating the consideration of astronaut health and performance in the vehicle 
design is essential.  The current research plan not only accounts for human factors research, but 
for the first time specifies that the design of medical systems should be integrated into the 
vehicle design.  The SRP commends the ExMC Element for working with other stakeholders to 
develop a user-friendly vehicle-based medical system. 
 
The following is a summary of the general comments and recommendations by the SRP: 
 
 The SRP agrees with the guiding principles of the ExMC Element as articulated through 
the new Concept of Operations, which allows for explicit tradeoffs of mass, volume, 
weight, risk, and capability. 
 
 The SRP recommends a clearer articulation of the policies and procedures used to 
transfer knowledge and tools developed by the ExMC Element to NASA operations. 
 
 The SRP notes that although the exploration paradigm requires functioning in an 
environment containing limited resources, data handling capability is growing rapidly 
which can be an opportunity for achieving goals of the ExMC Element. 
 
 The Concept of Operations, as specified into two computer models: 1) the Integrated 
Medical Model (IMM) and 2) the Medical Optimization Network for Space Telemedicine 
Resources (MONSTR), enables flexibility in identifying research needs and 
recommending medical capability.  This will be important as medical knowledge about 
the health effects of space flight and medical device technology develops. 
 
 The IMM is an important tool to forecast medical outcomes for inflight operations and 
medical impacts to missions.  The IMM models the burden of risk for various conditions 
according to their: 1) likelihood in bins of increasing probability; and 2) consequences of 
the condition on mission health and performance in bins of increasing morbidity, given a 
specified diagnostic, treatment, and rehabilitation capability.  For condition-specific risks 
this “risk modeling tool” allows for steps to be taken to decrease the risk burden.  The 
likelihood of risky conditions occurring can be decreased (i.e., to avoid consequences) by 
focused selection, screening, prevention, vehicle design standards, and mission 
architecture.  The morbidity consequences of risky conditions can be decreased by proper 
application of medical capability (i.e., to minimize consequences) with appropriate 
diagnosis, treatment, chronic management, and rehabilitation.  Both processes decrease 
the likelihood and consequences of risky conditions and therefore can decrease their risk 
burden.  The methods for decreasing both likelihood and consequences of risks derive 
from five systems, including: 1) medical support; 2) technology development; 3) training; 
4) medical decision support software; and 5) integration of medical support with vehicle 
design and Environmental Control & Life Support System Maturation Teams.  The SRP 
thinks this approach is innovative for both quantifying and reducing risk. 
  
 The MONSTR, which is in an early stage of development, is a modeling tool that enables 
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greatest capability for a space mission.  The tool incorporates data from the IMM as to 
the likelihood of each expected condition in the IMM list and as well as the resources 
needed for each condition and how critically they are needed for each condition.  An 
optimal set of tools to bring into space can then be prioritized in this model, which was 
developed by NASA.  The MONSTR output is based on assumptions from: 1) the IMM 
about the likelihood and consequence of conditions given specific medical capabilities; 
and 2) an analysis of terrestrial standard of care related to the criticality of resources for 
treating each condition.  This model can provide measures of utility of each piece of 
medical technology (including drugs and devices).  These measures of utility then 
support decisions about risk tradeoffs given the mass, volume, and power available to the 
exploration medical capability. 
 
 Given the limited amount of resources that can be transported into space, the SRP 
believes that the MONSTR model could be very important for selecting the most useful 
medical technologies and training for space missions. 
 
 Together, the IMM and the MONSTR provide for specific, measurable, actionable, and 
transparent analysis of medical conditions, risks of these conditions, and risk tradeoffs 
associated with carrying various medical technologies (drugs, devices and equipment) 
into space.  The goal of using these programs is to select astronauts and equip vehicles to 
minimize risk.  The IMM and the MONSTR provide a foundation for organizing the 
ExMC’s work.  They provide resilience for future changes in medical knowledge, 
medical technology, and mission priorities.  Therefore, the IMM and the MONSTR 
should be a high priority for the ExMC Element, and the SRP recommends that 
additional resources be devoted to developing these computer models. 
 
 The SRP further recommends the ExMC Element consider developing a mathematical 
model that will assist crew members to make decisions about how to use consumable 
medical supplies while in-flight. 
 
 There is a gap in astronaut selection and it needs to be articulated.  The IMM estimates 
risks for conditions not frequently seen in space using published information from a wide 
variety of sources, such as actuarial tables published by the Centers for Disease Control.  
These sources can only approximate the risks faced by astronauts.  Astronaut selection 
(i.e., “prevention”) is a key component of the exploration medical capability, and a more 
systematic approach is needed to model the effect of astronaut selection on exploration 
risk.  For example, the IMM should be enhanced to address the questions like these: 
What is the effect (change in risk) of astronaut selection requiring higher preflight bone 
densities compared with lower preflight densities?  What is the change in risk associated 
with allowing a second-degree family history of cardiovascular disease (given sex, age, 
and other cardiovascular disease (CVD) risk factors) compared with not allowing this 
family history?  Where the data needed to model these questions is available in the 
medical literature, and then the resources should be provided to review these data and 
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 The SRP suggests that NASA seek input from astronaut-physicians who have worked in 
space, to help make these decisions about what type of medical care should be delivered 
in space. 
 
 The Concept of Operations and enhancements to the associated mathematical models will 
enable improved priority setting for future research (e.g., pharmacology and training). 
 
II. Critique of Gaps and Tasks for the Risk of Adverse Health Outcomes & 
Decrements in Performance due to Inflight Medical Conditions 
 
A. Have the proper Gaps been identified to mitigate the Risk? 
a. Are all the Gaps relevant? 
b. Are any Gaps missing? 
B. Have the gap targets for closure been stated in such a way that they are measureable and 
closeable? 
a. Is the research strategy appropriate to close the Gaps? 
C. Have the proper Tasks been identified to fill the Gaps? 
a. Are the Tasks relevant? 
b. Are there any additional research areas or approaches that should be 
considered? 
c. If a Task is completed, please comment on whether the findings contribute to 
addressing or closing the Gap. 
D. If a Gap has been closed, does the rationale for Gap closure provide the appropriate 
evidence to support the closure? 
 
Gaps and Tasks: 
A proper set of Gaps is presented in the ExMC Risk Research Plan.  The updated research plan 
incorporates (in addition to traditional risks to health and performance) renal, bone, and 
pharmacy Risks, which are appropriate topics for the ExMC Element to address. 
 
Med-01: We do not have a concept of operations for medical care during exploration 
missions.  
 The SRP recommends rewording the Gap title to more explicitly state its integrative 
function of the other ExMC Gaps: We do not have a concept of operations that integrates 
research activities related to the various aspects of exploration medical capability 
including operations research, information resources, and technology development. 
 
 The SRP commends the ExMC Element for defining a Concept of Operations 
(conceptual model) that integrates research needs related to conditions, risks, technology, 
skills, information, and capabilities. 
 
 This Gap addresses which medical conditions will receive care and the specific methods 
for delivering care.  The decision will be based, in part, on constraints resulting from lack 
of resupply or evacuation, limited availability of telemedicine care, and the well-known 
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removing the appendix preflight if it is determined that appendectomy in space will not 
be feasible? 
 
 The Concept of Operations enhances communication about the ExMC Element’s gaps, 
tasks, and goals. 
 
 The Concept of Operations provides a powerful tool in laying out research gaps in a 
manner that is logical, integrative, and well phased. 
 
 The framework is flexible in enabling the addition, in the future, of new knowledge and 
technological innovation. 
 
 Mapping of the Concept of Operations to the IMM is concrete and transparent. 
 
 By design, the Med-01 Gap will remain open until all other ExMC Gaps (below) close. 
 
 The following tasks were developed under the previous organization of the ExMC’s 
research plan, which has since undergone major reconsideration.  Those that are closed 
were appropriately closed.  Those that remain open are appropriate.  The planned tasks 
are appropriate, although select medical conditions could be reassigned to Med-12. 
 
Tasks: 
 ExMC Tech Watch – PI:  Michael Krihak, Ph.D. – NASA Ames Research Center 
 Study of the impact of long-term space travel on the astronaut's microbiome (SHFH) – 
PI:  Hernan Lorenzi, Ph.D. – J Craig Venter Institute  
 Improving CV Risk Prediction -- Biomarkers and Beyond, Implications for Astronaut 
Selection and Monitoring During Prolonged Spaceflight (CV BIOMARKERS / DE 
LEMOS / ACTIVE) – PI: James Andrew de Lemos, M.D., The University of Texas 
Southwestern Medical Center at Dallas 
 Human Research Wiki (Archived) – Completed Task  
 Cardiovascular Imaging and Strategies to Mitigate the Risk for Cardiac Events in 
Astronauts During Prolonged Spaceflight (Cardiac Risk-Imaging -- Levine, Completed) 
(HHC) – Completed Task  
 Evaluating the Spaceflight Infectious Disease Risk Potential of Pathogenic and 
Commensal microorganisms using Caenorhabditis elegans as a Human Surrogate Model 
for Infection (SHFH) – Completed Task  
 Determine requirements for inflight periodic health status exams based on Exploration 
Medical Condition List – Completed Task  
 Data Mining/Identification of characteristics associated with susceptibility to hypobaric 
environments – Completed Task  
 Development of Methods/Technologies for Dental Conditions – Completed Task  
 Research Treatment of Relevant Medical Conditions in Remote, Resource Poor 
Environments – Completed Task  
 ExMC Support of Medical Scenarios for the Autonomous Mission Operation (AMO) 
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 Development of Capability to Protect Medications in Spaceflight (Archived) – 
Completed Task 
 Data Sharing Activity to Gather Evidence for Impaired Healing Risk  (HHC) – Planned 
Task 
 
Med-02: We do not have the capability to provide a safe and effective pharmacy for 
exploration missions. 
 
 The SRP identified this Gap as being in the top tier of priority because pharmacy is a key 
modality for definitive treatment and is useful for differential diagnosis and presumptive 
treatment. 
 
 The main issue in this Gap is how to provide a safe and effective pharmacy given two 
questions that must be answered: 1) which drugs should be brought into space and for 
what indications; and 2) how can these drugs be kept safe from degradation to become 
ineffective and possibly from toxicity in case the product expiration date while a mission 
is still in progress and resupply is not possible? 
 
 SRP recommends that the pharmacology stability Risk should be incorporated into this 
Gap. 
 
 Given the research nature of exploration, it is important to clarify the human subject 
issues related to repackaging and other Food and Drug Administration (FDA) concerns.  
The SRP felt that permission to possibly provide drugs off label and/or past their 
expiration date was not clearly presented by the ExMC.  Such permission to possibly put 
astronauts at risk was not clearly described as either a NASA operational requirement per 
the Aerospace Medical Board or as an FDA-governed Institutional Review Board (IRB)-
approved research process (where benefits outweigh risks) with informed consent.  
Further clarification and closure of this issue was recommended. 
 
 Although the pharmacokinetics/pharmacodynamics (PK/PD) concern is still under the 
Human Health Countermeasures (HHC) Element, the SRP believes that it is critical that 
the ExMC Element interfaces with them and stay abreast of the status of the research.  
The SRP suggests four additional questions for the ExMC Element to work on: 1) Which 
drugs are needed in space missions and for which conditions? 2) What are the storage 
capabilities (including mass/volume? 3) What are the repackaging constraints? 4) Which 
adverse events and side effects occur from drugs that are used in space?  Key 
characteristics of drugs that relate to their packaging, storage, and use during a mission 
are not well integrated.  The SRP recommends use (or development) of a pharmacy 
database to synthesize this knowledge and improve knowledge-sharing across Human 
Research Program (HRP) Elements. 
 
 The Raman Spectroscopy Analyzer project and the 3D printing project should both 
undergo further testing.  These are promising approaches to ensuring safe and effective 








 Medication Stability Analysis: Device (Pharm 01) – PI: TBD 
 Retrospective Analysis of Medication Usage During Long Duration Spaceflight  (Pharm 
01) – PI: Virginia Wotring, Ph.D., NSBRI 
 Dose Tracker Application for Monitoring Crew Medication Usage, Symptoms and 
Adverse Effects During Missions  (Pharm 01) – PI: Virginia Wotring, Ph.D., NSBRI 
 Ground Stability Testing (Pharm 02) – Planned Task 
 Medication Stability Analysis: Method  (Pharm 02) – Planned Task 
 
Med-03: We do not know how to apply personalized medicine effectively to reduce health 
risk for a selected crew. 
 
 The SRP notes that the term “personalized medicine” has been reconceived by the 
National Institutes of Health to a more specific term: “precision medicine” 
(http://ghr.nlm.nih.gov/handbook/precisionmedicine/precisionvspersonalized).  Precision 
medicine uses big data and multiple types of physiological and genetic inputs to make 
predictions about the best selections of therapy.  Although this is cutting edge medicine, 
the SRP thinks it may be too early to get involved. 
 
 The SRP suggests the ExMC Element track/follow the work currently being done in the 
Advanced Environmental Health (Host Microbe) Project, specifically with respect to 
microbiome research, because the microbiome is one of the key environmental factors 
that drive genetic expression; can be altered by diet and drug exposures; and is itself a 
risk factor for diseases including infections and metabolic disease, among others.  
Knowledge of the microbiome is expanding rapidly. 
 
 The SRP agreed with the ExMC Element that various types of omics information should 
be obtained as technologies for such collections become available.  This information will 
facilitate development of a precision medicine database for each astronaut. 
 
 The SRP previously recommended and recommends again that full body images of 
astronauts be obtained in order to establish a medical baseline data for each astronaut. 
o The SRP recommends also obtaining baseline genetic/genome for each astronaut 
to see what happens after long-term exposure to radiation. 
o This could be a possible new task or add this to the current baseline data that is 
already being collected from the astronauts. 
 
No current tasks 
 
Med-04: We do not have a defined rehabilitation capability for injured or de-conditioned 
crew members during exploration missions. 
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 The new gaps are important specifically for inflight rehabilitation. 
 
 The SRP believes this Gap may require more study to define the inflight requirements 
and countermeasures and could be incorporated into the MONSTR. 
 
 This Gap deals with rehabilitation in microgravity and a better solution is needed 
operationally to achieve such rehabilitation. 
 
 The SRP applauds the goal of dual-use equipment for both rehabilitation and 
conditioning, as well as the potential identification by the ExMC Element of non-exercise 
technologies for rehabilitation. 
 
 The SRP agrees with how the 100 IMM conditions are now classified according to organ 
system rather than in alphabetical order, which was the case in the past. 
 
 The SRP recommends adding asthma/bronchospasm and muscle cramps to the IMM list. 
  
Tasks: 
 Risk of Intervertebral Disc Damage After Prolonged Spaceflight (HHC) – PI: Alan 
Hargens, Ph.D., University of California - San Diego 
 Sonographic Astronaut Vertebral Examination (HHC) – PI: Scott Dulchavsky, M.D., 
Ph.D., Henry Ford Health System 
 Development of capability to treat musculoskeletal injuries – Planned Task 
 
Med-05: We do not know how to train crew for medical decision making and medical skills 
to enable extended mission or autonomous operations. 
 
 The SRP agrees with how this is being addressed in the IMM model with respect to 
incorporating this knowledge into the medical decisions and skills.  There is an emphasis 
on training methods in general rather than on a specific task that is the subject of the 
training. 
 
 The ExMC Element distinguishes two types of training: 1) Procedures and 2) Medical 
decision making.  The SRP agrees that the approach used to medical decision making 
will be critical to operational success. 
 
 This Gap addresses the idea of autonomy without ground support very well. 
 
 The SRP recommends that the ExMC Element seek input from an expert who is 
knowledgeable in adaptive or perceptual learning – novel way to educate crew members. 
This process should begin on the ground and utilize stored modules on the vehicle that 
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 Clinical Outcome Metrics for Optimization of Robust Training – PI: Douglas Ebert, 
Ph.D., NASA Johnson Space Center 
 Assisted Medical Procedures – Completed Task 
 Integration of iRevive with the Lightweight Trauma Module – Completed Task 
 ExMC Support of Medical Scenarios for the Autonomous Mission Operation (AMO) 
Test – Completed Task 
 Medical training methods for exploration missions– Completed Task 
 Medical Proficiency Training  (SHFH) – Completed Task 
 Data mining for telementoring studies and practices – Completed Task 
 Telemedicine Workshop – Completed Task 
 Air/Fluid Separation in a Syringe in a Microgravity Environment – Completed Task 
 Electronic Procedures for Crewed Missions Beyond Low Earth Orbit (LEO) (SHFH) – 
Planned Task 
 Evaluation of Task-Skill-Knowledge JIT techniques for medical and other emergency 
events (SHFH) – Planned Task 
 Advanced concepts for information integration and presentation (SHFH, Archived) – 
Planned Task 
 
Med-06: We do not know how to define medical planning or operational needs for ethical 
issues that may arise during exploration missions. 
 
 The SRP is concerned that Med-06 implicitly contains concepts related to planning for 
severe injuries and loss of crew life.  The SRP recommends that treatment with palliative 
intent be explicitly planned as a medical capability in Med-07.  Palliative care provides 
for the development and implementation of protocols to ease suffering and improve the 
quality of life for both the dying/disabled crew member and the rest of the crew.  Ethical 
issues are separate from palliative care capabilities. 
 
 With respect to medical ethics, one need is to train crew members to make ethical 
judgments to weigh the value of extraordinary medical treatment to one crew member 
that may place other crew members at increased risk.  This could be an educational 
module (make astronauts and ground crew more comfortable with decision making using 
Ethics frameworks).  Creation of scenarios for training the crew could be a new task 
under this Gap. 
 
 The SRP recommends that a medical ethicist be engaged to help guide the articulation of 
relevant research questions. 
 
No current tasks 
 
Med-07: We do not have the capability to comprehensively process medically-relevant 
information to support medical operations during exploration missions. 
 
 The SRP believes that it is important to continue the development of an agile health 
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 The Exploration Medical System Demonstration (EMSD) is an important tool to defining 
the medical capability for exploration missions. 
 
 As more information is gathered, the compatibility of data must be considered for all 
devices, both ground and in-flight. 
o Middleware can convert multiple inputs into a common language for transmission 
to Earth. 
 
 The SRP recommends that automatic physiological data uploading for astronauts be 
utilized to avoid incomplete compliance and/or entry errors. 
 
 The SRP agreed with the ExMC Element’s plan to use an electronic medical record 
(EMR) that includes only medical information and no billing or administrative inputs to 
streamline use and not waste time. 
 
Tasks: 
 Biosensors for Medical System – PI: Bill Toscano, Ph.D., NASA Ames Research Center 
 Medical Consumables Tracking – PI: John Zoldak, Ph.D., ZIN Technologies 
 Exploration Medical System – Completed Task 
 Middleware for Medical System – Completed Task 
 Electronic Medical Records – Completed Task 
 Dental for Medical System – Completed Task 
 Assisted Medical Procedures – Completed Task 
 Distributed System for Spaceflight Biomedical Support – Completed Task 
 Exploration Medical System Demonstration (EMSD) Baseline Capability Evaluation 
using the Habitation Development Unit (HDU) – Completed Task 
 ExMC Support of Medical Scenarios for the Autonomous Mission Operation (AMO) 
Test – Completed Task 
 
Med-08: We do not have quantified knowledge bases and modeling to estimate medical risk 
incurred on exploration missions.  
 
 The SRP encourages NASA to utilize modeling where ever possible: 
o Modeling allows prioritization of medical capabilities. 
o Modeling allows NASA to quantify risk (IMM) and prioritize resources 
(MONSTR). 
 
 The IMM and MONSTR efforts are in the top tier of priority and should be moved 
forward quickly. 
o This type of modeling capability could address many of the issues that the ExMC 
Element will encounter. 
o The best case scenario and worst case scenario approach to modeling outcomes, 
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 The method used to incorporate lessons learned during the development of the IMM and 
the MONSTR was not clearly explained.  These lessons should be used for future 
modeling efforts. 
 
 The SRP would like to see modeling used inflight (relevant to Gap Med-08 and Med-09).  
 
 The SRP thinks the current 8 – 12 week time required for the review process to accept 
new IMM modeling outputs is long. 
o The SRP suggests that the ExMC Element look at new methods to speed up the 
output validation/review process. 
 
 The SRP understands that the IMM forecasts outcomes only for inflight operations and 
not post-mission medical consequences. 
o The SRP recommends considering a postflight medical consequences modeling 
effort as well. 
 
 The Crew Health Index (CHI) is an appropriate measure (defined as proportion of 
mission time not lost to medical events). 
 
Tasks: 
 Integrated Medical Model (IMM) – PI: Douglas Butler, NASA Johnson Space Center  
 Integrated Medical Model - Renal Stone Module – PI: Jerry Myers, Ph.D., NASA Glenn 
Research Center  
 Integrated Medical Model - Bone Module – PI: TBD 
 Metric Development to Quantify Change in Mission Risk Due to a Physician-Trained 
Crew Medical Officer – PI: Jerry Myers, Ph.D., NASA Glenn Research Center   
 Clinical Outcome Metrics for Optimization of Robust Training – PI: Douglas Ebert, 
Ph.D., NASA Johnson Space Center  
 Integrated Medical Model - Chest Injury Module – Completed Task 
 Integrated Medical Model - Head Injury Module – Completed Task 
 Integrated Medical Model - Abdominal Injury Module – Completed Task 
 Integrated Medical Model - Bayesian Analysis – Completed Task 
 Integrated Medical Model - Neck Injury Module – Completed Task 
 Integrated Medical Model - Sleep Module – Completed Task 
 Intuitive Ultrasound Catalog for Autonomous Medical Care – Completed Task 
 ExMC Support of Medical Scenarios for the Autonomous Mission Operation (AMO) 
Test – Completed Task 
 Quantify impacts of physician training on medical task performance – Terminated Task 
 
Med-09: We do not have the capability to predict estimated medical risk posture during 
exploration missions based on current crew health and resources. 
 
 The SRP recommends rewording the Gap title for clarity to: We do not have the 
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as medical resources are used and crew health declines. 
 
 The SRP agrees that an accurate inventory of consumables is important and that research 
should be continued until this Gap is closed. 
 
 The SRP recommends that a mathematical model be developed to help the crew/ground 
control appropriately ration consumable medical resources based on crew health and 
remaining stocks. 
 
 The SRP suggest that the ExMC Element explore the use of smart pills (electronically 
tagged) once they are approved by the FDA.  They may be useful in tracking drug 
delivery. 
 
 The Medical Consumables task (below) is relevant and could be tested in a ground 
analog, if implementation questions remain. 
 
Tasks: 
 Medical Consumables Tracking – PI: John Zolda, Ph.D., ZIN Technologies 
 
Med-10: We do not have the capability to provide computed medical decision support 
during exploration missions. 
 
 Computerized clinical decision support can incorporate sensor data, images, history, 
exercise capabilities, and environmental data.  This software should be used as an integral 
component of the electronic medical record.  Such software will be needed on trips into 
deep space where ground support will take too long to be a sole source of useful advice 
for acute problems. 
 
 Decision support software already exists and evolves as medical knowledge expands and 
new diagnostic and treatment modalities become available. 
 
 To help the crew use computerized decision support, we recommend consideration of 
software designed with high quality User Interface/User Experience (UI/UX) programs. 
 
 The SRP recommends incorporating natural language recognition/analysis into decision 
support, such as Amazon Echo. 
 
Tasks: 
 Integration of iRevive with the Lightweight Trauma Module – Completed Task 
 ExMC Support of Medical Scenarios for the Autonomous Mission Operation (AMO) 
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Med-11: We do not have the capability to minimize medical system resource utilization 
during exploration missions. 
 
 The SRP was impressed by this effort to maximize limited resources by repurposing tools 
and other resources to allow conservation of mass, volume, and energy.  This Gap is 
intended to use technologies intended for medical purposes for non-medical purposes and 
vice versa.  An example is to use an x-ray device to also assess performance of an 
electronics module. 
 
 This Gap is not expected to close because new technologies are constantly being 
developed and some of them might be suitable for cross-cutting purposes that are both 
medical and non-medical. 
 
 The ExMC no longer has a Tech Watch under this Gap, and the SRP believes that a 
replacement is needed. 
 
No current tasks 
 
Med-12: We do not have the capability to mitigate select medical conditions. 
 
 The SRP is pleased that the ExMC Element has moved previous research risks into 
operations, particularly the bone fracture risk, the renal stone risk and the stability risk. 
 
 This Gap includes specific risks that have been recently assigned to it (bone disease and 
renal stones), as well as legacy gaps including musculoskeletal injuries and exposure to 
lunar dust. 
 
 The SRP supports that this Gap will utilize dual-use devices for both diagnoses and 
treatment (e.g., x-ray). 
 
 The SRP is pleased with the work the ExMC Element is doing with General Electric on a 
flexible ultrasound technology that can reposition renal stones (which occur more 
frequently in space because of microgravity, dehydration, and hypercalciuria from bone 
mineral loss) when they are stuck and painful and also detect small stones by way of a 
twinkling artifact. 
 
 The SRP is pleased that the ExMC Element is using the ultrasound technology to detect 
bone mineral loss, and provide therapy for fractures and musculoskeletal back pain. 
 
Tasks: 
 Portable Quantitative Ultrasound with DXA/QCT and FEA Integration for Human 
Longitudinal Critical Bone Quality Assessment – PI: Yi-Xian Qin, Ph.D., SUNY- The 
State University of New York 
 Flexible Ultrasound System for Quantitative Diagnosis and Therapeutic Ultrasound – PI: 
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 Risk of Intervertebral Disc Damage After Prolonged Spaceflight (HHC) – PI: J Alan 
Hargens, Ph.D., University of California - San Diego 
 Sonographic Astronaut Vertebral Examination (HHC) – PI: Scott Dulchavsky, M.D., 
Ph.D., Henry Ford Health System 
 Prevention of Renal Stone Complications in Space Exploration – PI: Michael Bailey, 
Ph.D., University of Washington 
 Integrated Medical Model - Renal Stone Module – PI: Jerry Myers, Ph.D., NASA Glenn 
Research Center  
 Wearable, Sustained Acoustic Medicine for Back Pain – PI: TBD 
 Combined Scanning Confocal Ultrasound Diagnostic and Treatment System for Bone 
Quality Assessment and Fracture Healing – Completed Task 
 Ultrasound Fracture Diagnosis in Space – Completed Task 
 LADTAG Lunar Dust Health Standard (SHFH) – Completed Task 
 Clearance of Particles Depositing in the Human Long in Low-Gravity (SHFH) – 
Completed Task 
 Improving Kidney Stone Detection in Space Analogs – Completed Task 
 Development of capability to treat musculoskeletal injuries – Planned Task 
 Development of capability to treat bone fractures – Planned Task  
 Development of Capability to Monitor and Treat Disease Caused by Dust Exposure 
During Exploration Missions – Planned Task 
 
Med-13: We do not have the capability to implement medical resources that enhance 
operational innovation for medical needs. 
 
 This Gap describes 10 capabilities to provide, generate, prevent and other processes.  
These capabilities all describe enabling technologies.  Therefore the SRP suggests that 
the Gap title include “implementing technologies for medical needs”. 
 
 Dual use devices and solutions are valuable for resource management (crew time, energy, 
weight, etc.) incorporating technologies with multiple functions. 
 
 Unlike Gap Med-11, which promotes development of cross-cutting technologies for both 
medical and nonmedical uses, Gap Med-13 promotes technologies for a variety of 
specific medical conditions.  The SRP supports the utilization of dual use technologies 
for both gaps. 
 
Tasks: 
 Oxygen Delivery System – PI: Sandra Olson, Ph.D., NASA Glenn Research Center  
 Exploration Laboratory Analysis – PI: Michael Krihak, Ph.D. – NASA Ames Research 
Center 
 Cell Phone-based Lateral Flow Assay for Blood Biomarker Detection – PI: Manal 
Beshay, Ph.D., Intelligent Optical Systems, Inc. 
 IVGEN PostFlight Analysis – PI: John McQuillen, Ph.D., NASA Glenn Research Center  
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Flexible Ultrasound System – PI: William Thompson, Ph.D., NASA Glenn Research 
Center 
 Wideband Single Crystal Transducer for Bone Characterization – PI: Kevin Snook, 
Ph.D., TRS Ceramics, Inc. 
 Portable Quantitative Ultrasound with DXA/QCT and FEA Integration for Human 
Longitudinal Critical Bone Quality Assessment] – PI: Yi-Xian Qin, Ph.D., SUNY- The 
State University of New York 
 Flexible Ultrasound System for Quantitative Diagnosis and Therapeutic Ultrasound PI: 
William Thompson, Ph.D., NASA Glenn Research Center 
 Non-Invasive Monitoring of Intracranial Pressure (ICP) with Volumetric Ophthalmic 
Ultrasound [ULTRASOUND ICP/DENTINGER/ACTIVE] (HHC) – PI: Aaron 
Dentinger, Ph.D., NGE Global Research 
 Non-Invasive Monitoring of Intracranial Pressure with Volumetric Ophthalmic 
Ultrasound: Integration with NASA’s Flexible Ultrasound System (FUS) – PI: Aaron 
Dentinger, Ph.D., NGE Global Research 
 JAXA Auscultation Data Review – PI: Douglas Ebert, Ph.D., NASA Johnson Space 
Center 
 Combined Scanning Confocal Ultrasound Diagnostic and Treatment System for Bone 
Quality Assessment and Fracture Healing – Completed Task 
 Intuitive Ultrasound Catalog for Autonomous Medical Care – Completed Task 
 Ultrasound Fracture Diagnosis in Space – Completed Task 
 Validation of On-Orbit Methodology for the Assessment of Cardiac Function and 
Changes in the Circulating Volume Using Ultrasound and Braslet-M Occlusion Cuffs, 
SDTO 17011 U/R (Braslet-M -- Duncan, Completed) – Completed Task 
 Multi-Use Near-Infrared Spectroscopy System for Spaceflight Health Applications – 
Completed Task 
 First Clinical Test of Feasibility of Ultrasound to Reposition Kidney Stones – Completed 
Task 
 Development of Pressure Swing Adsorption Technology for Spaceflight Medical Oxygen 
Concentrators – Completed Task 
 Evaluation of Oxygen Concentrators at Altitude – Completed Task 
 Portable Cathode-Air-Vapor-Feed Electrochemical Medical Oxygen Concentrator – 
Completed Task 
 Lightweight Trauma Module – Completed Task 
 In-flight Blood Analysis Technology for Astronaut Health Monitoring – Completed Task 
 Nanoscale Test Strips for Multiplexed Blood Analysis – Completed Task 
 Reusable Handheld Electrolytes and Lab Technology for Humans – Completed Task 
 IntraVenous Fluid GENeration for Exploration Missions – Completed Task 
 Smart Therapeutic Ultrasound Device for Mission-Critical Medical Care – Completed 
Task 
 ExMC Support of Medical Scenarios for the Autonomous Mission Operation (AMO) 
Test – Completed Task 
 Lightweight, Wearable Metal Rubber-Textile Sensor for In-Situ Lunar Autonomous 
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 Lunar Health Monitor: A Wearable System to Monitor Astronaut Health Status – 
Completed Task 
 Wearable Health Monitoring Systems – Completed Task 
 Biomedical Sensors Requirements for Extravehicular Activities – Completed Task 
 Intraosseous (IO) Access Device Demonstration – Completed Task 
 Development of Medical Suction Technology – Planned Task 
 Development of Capability for Algorithm-based Fluid Resuscitation – Planned Task 
 Development of Capability to Irrigate the Eye – Planned Task 
 Development of Capability to Sterilize Medical Equipment in Spaceflight – Planned Task 
 Spaceflight Injectable Delivery System – Terminated Task 
 Review and Assess State of Knowledge Regarding the Acute or Chronic Cardiovascular 
Toxicity of Mineral Dusts  (SHFH, Archived) – Terminated Task 
 
III. Discussion on the strengths and weaknesses of the IRP and identify 
remedies for the weaknesses, including answering these questions: 
 
A. Is the Risk addressed in a comprehensive manner? 
 
The SRP believes that the Risk is addressed in a comprehensive manner and the ExMC 
Element is doing a good job in determining the tradeoffs to minimize the Risk. 
 
B. Are there areas of integration across HRP disciplines that are not addressed that 
would better address the Risk? 
 
The SRP thinks that the current integration between the ExMC Element and other HRP 
Elements is appropriate.  The ExMC Element should be frequently updated on the 
research being done in all of the HRP Elements, and especially by HHC, since once these 
Risks are no longer research Risks and are ready to become medical Risks, they will fall 
under the ExMC Element. 
 
The SRP recommends that the ExMC Element try to receive input and involvement from 
the flight surgeons office as early in the process as possible. 
 
IV. Evaluation of the progress on the ExMC Research Plan since the 2014 
SRP meeting 
 
Overall, the SRP was impressed with the many positive changes made to the ExMC 
Research Plan since the 2014 SRP review. 
 
V. Additional Comments 
 
 Consideration should be given to more explicitly addressing astronaut selection to 
prevent risk.  The actual level of health risk, given selection criteria, should be 
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 The current Path to Risk Reduction (PRR) addresses the Risk in two different ways: 
1) It decreases likelihood (prevention) and 2) It decreases severity and consequences 
(enhanced medical capabilities).  For condition-specific risks, this approach offers 
two different ways to decrease the risk burden.  With the IMM model, risk 
mitigation can occur either by decreasing the likelihood and preventing risks from 
occurring or else by decreasing the morbidity of the risk through early diagnosis and 
treatment/rehabilitation.  However, for other conditions that are either not part of the 
IMM list of 100 conditions or for which too little data are available for modeling, 
there can still be an unspecified level of medical risk present that cannot be 
quantified, predicted, or mitigated. 
 
 It would help to have realistic scenarios for mass, power, and volume (although they 
are uncertain) to assist with modeling efforts. 
 
 Focusing on the proving-ground paradigm is good, but NASA must be prepared for 
exploration missions. 
 
 The SRP believes that long-term health, i.e., lifetime health, is out of scope of this 
plan.  Questions about lifetime health are basic research questions that lead to the 
creation of new knowledge.  Questions about the exploration medical capability are 
applied research questions that lead to the creation of new operations, technologies, 
and systems.  The expertise and methods needed to generate questions, 
conceptualize projects, and study lifetime health are different from those needed to 
predict and protect astronaut health during an exploration.  Furthermore, how 
information about lifetime health would be used to design future missions is not 
clearly conceived.  The SRP is concerned that studying lifetime health distracts the 
ExMC from its more urgent and essential goals. 
 
o One possibility is to carve out the Lifetime Health gap for assignment to a 
separate group or individual.  A scientist focused on lifetime health among 
exploration astronauts needs a level of competency with epidemiologic methods 
used to study the long-term health effects of radiation; this is a specific set of 
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VI. 2015 ExMC SRP Research Plan Review: Statement of Task for the Risk 
of Adverse Health Outcomes & Decrements in Performance due to 
Inflight Medical Conditions 
 
The 2015 Exploration Medical Exploration (ExMC) Standing Review Panel (SRP) is chartered 
by the Human Research Program (HRP) Chief Scientist.  The purpose of the SRP is to review the 
Risk of Adverse Health Outcomes & Decrements in Performance due to Inflight Medical 
Conditions (ExMC Risk) section of the current version of the HRP’s Integrated Research Plan 
(IRP) which is located on the Human Research Roadmap (HRR) website 
(http://humanresearchroadmap.nasa.gov/).  Your report, addressing each of the questions in the 
charge below and any addendum questions, will be provided to the HRP Chief Scientist and will 
also be made available on the HRR website. 
 
The 2015 ExMC SRP is charged (to the fullest extent practicable) to: 
1. Based on the information provided in the current version of the HRP’s IRP, evaluate the 
ability of the IRP to satisfactorily make progress in mitigating the Risk by answering the 
following questions: 
 
A. Have the proper Gaps been identified to mitigate the Risk? 
i) Are all the Gaps relevant? 
ii) Are any Gaps missing? 
 
B. Have the gap targets for closure been stated in such a way that they are measureable 
and closeable? 
i) Is the research strategy appropriate to close the Gaps? 
 
C. Have the proper Tasks been identified to fill the Gaps? 
i) Are the Tasks relevant? 
ii) Are there any additional research areas or approaches that should be considered? 
iii) If a Task is completed, please comment on whether the findings contribute to 
addressing or closing the Gap. 
 
D. If a Gap has been closed, does the rationale for Gap closure provide the appropriate 
evidence to support the closure? 
 
2. Identify the strengths and weaknesses of the IRP, and identify remedies for the weaknesses, 
including, but not limited to, answering these questions: 
A. Is the Risk addressed in a comprehensive manner? 
B. Are there areas of integration across HRP disciplines that are not addressed that would 
better address the Risk? 
C. Other 
 
3. Based on the updates provided by the Element, please evaluate the progress in the research 
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4. Please comment on any important issues that are not covered in #1, #2, or #3 above, that the 
SRP would like to bring to the attention of the HRP Chief Scientist and/or the Element.   
 
Additional Information Regarding This Review: 
 
1. Expect to receive review materials at least four weeks prior to the meeting.   
 
2. Attend a meeting in Houston, TX on December 10 - 11, 2015. 
A. Discuss the 2015 ExMC SRP Statement of Task and address questions about the SRP 
process. 
B. Receive presentations from the HRP Chief Scientist (or his designee), the ExMC 
Element, and participate in a question and answer session, and briefing. 
 
3. Prepare a draft final report (approximately one month after the meeting) that contains a 
detailed evaluation of the current IRP specifically addressing items #1, #2, and #3 of the SRP 
charge.  The draft final report will be sent to the HRP Chief Scientist and he will forward it to 
the appropriate Element for their review.  The ExMC Element and the HRP Chief Scientist 
will review the draft final report and identify any misunderstandings or errors of fact and 
then provide official feedback to the SRP within two weeks of receipt of the draft report.  If 
any misunderstandings or errors of fact are identified, the SRP will be requested to address 
them and finalize the 2015 SRP Final Report as quickly as possible.  The 2015 SRP Final 
Report will be submitted to the HRP Chief Scientist and copies will be provided to the ExMC 
Element and also made available to the other HRP Elements.  The 2015 SRP Final Report 
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VII. 2015 ExMC Standing Review Roster 
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Bernard Harris, Jr., M.D. 
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Department of Surgery 
10833 Le Conte Avenue 
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Los Angeles, CA  90095 
Ph: 310-206-7235 
Email: EDutson@mednet.ucla.edu  
 
Lisa Herrinton, Ph.D. 
Kaiser Permanente 
Division of Research  
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David Klonoff, M.D. 
Mills-Peninsula Health Services 
Diabetes Research Institute 
100 South San Mateo Drive 
Room 5147 
San Mateo, CA  94404 
Ph: 650-218-1142 
Email: dklonoff@diabetestechnology.org 
 
 
 
